LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

STATE STREET CORP's Holding History (CIK: 0000093751)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 3,702,440 Value ($000) $1,992 Avg Close Range
Q4 2024
Shares 3,748,673 Value ($000) $2,399 Avg Close Range
Q3 2024
Shares 3,889,553 Value ($000) $5,368 Avg Close Range
Q2 2024
Shares 3,818,320 Value ($000) $5,537 Avg Close Range
Q1 2024
Shares 3,717,963 Value ($000) $8,291 Avg Close Range
Q4 2023
Shares 3,539,086 Value ($000) $6,866 Avg Close Range
Q3 2023
Shares 6,810,428 Value ($000) $10,011 Avg Close Range
Q2 2023
Shares 6,171,245 Value ($000) $19,625 Avg Close Range
Q1 2023
Shares 7,921,252 Value ($000) $18,694 Avg Close Range
Q4 2022
Shares 8,750,419 Value ($000) $30,364 Avg Close Range
Q3 2022
Shares 5,379,838 Value ($000) $39,434 Avg Close Range
Q2 2022
Shares 2,595,919 Value ($000) $16,925 Avg Close Range
Q1 2022
Shares 1,890,929 Value ($000) $9,549 Avg Close Range
Q4 2021
Shares 419,184 Value ($000) $3,244 Avg Close Range
Q3 2021
Shares 283,802 Value ($000) $4,200 Avg Close Range